These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3765415)

  • 21. [Effect of blood components in hemotherapy on the factors of anti-infectious protection in patients with acute leukemias].
    Martynova VA; Abakumov EM; Ermakova GL; Pobedinskaia IN
    Gematol Transfuziol; 1988 Aug; 33(8):16-9. PubMed ID: 3192049
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on blood component transfusion with continuous blood cell separator (IBM 2997). Part 2: methods of granulocyte and platelet harvesting and efficacies of the component transfusion].
    Toki H; Ishikawa M
    Rinsho Ketsueki; 1982 Apr; 23(4):441-8. PubMed ID: 7131790
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of granulocyte transfusions collected from nonstimulated donors.
    Curtis JE
    Prog Clin Biol Res; 1982; 88():61-73. PubMed ID: 7100219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood component transfusion in bone marrow transplant patients].
    Harada M; Matsue K; Misawa T; Aoyagi N; Nakao S; Ueda M; Kondo K; Odaka K; Ohtake S; Teshima H
    Rinsho Ketsueki; 1983 Sep; 24(9):1277-84. PubMed ID: 6363749
    [No Abstract]   [Full Text] [Related]  

  • 25. Review of definitions and mechanisms of refractoriness to platelet transfusions.
    Hester JP; Ventura GJ
    Prog Clin Biol Res; 1990; 337():49-58. PubMed ID: 2191338
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thrombocyte substitution in hematologic patients].
    Wiesneth M
    Beitr Infusionsther; 1993; 31():86-91. PubMed ID: 7693270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
    Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The current status and problems associated with platelet transfusion].
    Kimura A
    Rinsho Byori; 1982 Oct; 30(10):1074-80. PubMed ID: 7182580
    [No Abstract]   [Full Text] [Related]  

  • 29. [Replacement therapy with blood components in bone-marrow depression due to cytostatic drugs (author's transl)].
    Höcker P; Pittermann E; Mann M; Krasa E
    Wien Klin Wochenschr; 1980 Aug; 92(15):530-5. PubMed ID: 7001766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Leukocyte transfusions in the treatment of sepsis].
    Tulupov AN; Mel'nikova VN; Volkova SD; Pleshakov VT; Bel'skikh AN; Il'ina EF; Popov VI
    Vestn Khir Im I I Grek; 1991 Jun; 146(6):72-6. PubMed ID: 1668512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet transfusions in 75 patients undergoing autologous bone marrow transplantation.
    Lund BV; Madsen M
    Transplant Proc; 1994 Jun; 26(3):1825. PubMed ID: 8030156
    [No Abstract]   [Full Text] [Related]  

  • 32. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experience in the treatment of acute leukemia with blood transfusions containing a large amount of leukocytes].
    El'kis NIa; Berman MA; Vakulenko SA
    Probl Gematol Pereliv Krovi; 1971 Jul; 16(7):51-2. PubMed ID: 5124641
    [No Abstract]   [Full Text] [Related]  

  • 34. Supportive care: twenty years of progress.
    Jaffe N; Buell DN
    Pediatr Ann; 1978 Jul; 7(7):508-11. PubMed ID: 97615
    [No Abstract]   [Full Text] [Related]  

  • 35. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
    Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunotherapy of acute leukoses].
    Krepler P
    Krebsarzt; 1969; 24(4):208-20. PubMed ID: 4190048
    [No Abstract]   [Full Text] [Related]  

  • 37. [Thrombocyte substitution. I. Indications and clinical use of thrombocyte transfusion].
    Anders O; Preussner S; Konrad H
    Z Gesamte Inn Med; 1986 Nov; 41(21):592-5. PubMed ID: 3825211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant reduction of sensitization and improved allograft outcome with donor-specific buffy coat transfusion.
    Okazaki H; Takahashi H; Miura K; Ishizaki M; Taguchi Y
    Transplantation; 1984 May; 37(5):523-5. PubMed ID: 6233767
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lymphocyte contamination in thrombocyte concentrates from individual blood stores].
    Aulmann HM; Bremer A; Kathmann G; Müller R; Naumann V; Robin-Winn M; Stangel W
    Beitr Infusionsther; 1988; 21():109-12. PubMed ID: 2462954
    [No Abstract]   [Full Text] [Related]  

  • 40. [Development of aggregation in store thrombocyte concentrates].
    Aulmann HM; Müller R; Stangel W
    Beitr Infusionsther; 1988; 21():103-8. PubMed ID: 2462953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.